(Q46427392)

22 December 2017

title

Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population (English)

1 reference

22 December 2017

1 reference

Qitian Mu

1

1 reference

22 December 2017

Qiuling Ma

2

1 reference

22 December 2017

Yungui Wang

3

1 reference

22 December 2017

Zhimei Chen

4

1 reference

22 December 2017

Xiangmin Tong

5

1 reference

22 December 2017

Fei-Fei Chen

6

1 reference

22 December 2017

Ying Lu

7

1 reference

22 December 2017

Jie Jin

8

1 reference

22 December 2017

language of work or name

1 reference

15 February 2012

1 reference

22 December 2017

published in

Annals of Hematology

1 reference

22 December 2017

volume

91

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

1065-1072

1 reference

22 December 2017

Chronic myeloid leukemia: diagnosis and treatment

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

The biology of CML blast crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Sequential karyotype study on Ph-positive chronic myelocytic leukemia. Significance of additional chromosomal abnormalities during disease evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Epidemiology of chronic myeloid leukaemia (CML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Management of chronic myeloid leukemia in France: a multicentered cross-sectional study on 538 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Chronic myeloid leukemia in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Public Health and Air Pollution in Asia (PAPA): a multicity study of short-term effects of air pollution on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

The cytogenetic scenario of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Molecular biology of bcr-abl1-positive chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-012-1421-6

10.1007/S00277-012-1421-6

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017